Looking ahead to 2025, Sandoz said it expects net sales to grow by a mid-single digit percentage in constant currencies.

The 25% US tariffs on Canada and Mexico have put into question a three-decade-long free trade agreement in North America.

The deal, disclosed on Wednesday 5 March, will see Jazz pay $8.55 per share, representing a 72.4% premium to Chimerix’s 4 ...

Container Closure Integrity Testing (CCIT) is a critical quality check for pharmaceuticals. In this article we give a brief ...

Antengene’s Xpovio NDA has gained approval from the Indonesia National Agency of Drug and Food Control for three indications.

WuXi Biologics has launched the E. coli expression system, EffiX, designed to enhance the production of recombinant proteins ...

Asceneuron is the latest biotech to face setbacks in developing tau-targeting therapies for Alzheimer’s. After Eli Lilly and ...

Experts debate whether European manufacturers are preferring domestic operations as the continent competes with Asia and the ...

The US Food and Drug Administration (FDA) has approved BeiGene’s Tevimbra (tislelizumab-jsgr) along with platinum-containing ...

AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommendation for approval in the EU to treat NSCLC.

Callio Therapeutics has raised $187m in Series A financing round for achieving clinical proof-of-concept for HER2-targeted ...

Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years ...